Scout | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)

This grant opportunity seeks to fund clinical research focused on non-invasive brain stimulation (NIBS) to uncover new targets that relate to neurobiological, cognitive, and behavioral responses linked to substance use disorders (SUD). The aim is to find responses that occur before clinical outcomes like reduced cravings or drug use. The research is expected to be exploratory, accepting risks …

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Award

Award Ceiling: $600,000

Funding Amount: $600,000

Dates

Opportunity Released: September 29, 2023

Open for Submission: September 29, 2023

Submission Deadline: August 14, 2026

Application Window Closes: August 14, 2026

Keywords

non-invasive brain stimulation

NIBS

substance use disorder

SUD

clinical research

novel targets

neurobiological responses

cognitive responses

behavioral responses

clinical trial

R61/R33 Phased Innovation award

mechanistic studies

pathophysiology

NIH

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers